FORTALEZA ASSET MANAGEMENT INC/ - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 177 filers reported holding NEKTAR THERAPEUTICS in Q1 2016. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.

Quarter-by-quarter ownership
FORTALEZA ASSET MANAGEMENT INC/ ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q2 2018$149,000
-68.3%
3,050
-31.1%
1.21%
-57.7%
Q1 2018$470,000
+19.9%
4,425
-32.5%
2.86%
+16.0%
Q4 2017$392,000
+59.3%
6,560
-36.0%
2.46%
+447.3%
Q3 2017$246,000
+23.0%
10,2500.0%0.45%
+18.4%
Q2 2017$200,000
+4.2%
10,250
+25.0%
0.38%
-2.3%
Q1 2017$192,000
+90.1%
8,2000.0%0.39%
+81.8%
Q4 2016$101,000
-99.9%
8,2000.0%0.21%
+8.6%
Q3 2016$140,876,000
+122400.9%
8,200
+1.2%
0.20%
+109.6%
Q2 2016$115,000
-99.9%
8,105
+35.0%
0.09%
+80.8%
Q1 2016$82,568,000
+81650.5%
6,0050.0%0.05%
-14.8%
Q4 2015$101,0006,0050.06%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q1 2016
NameSharesValueWeighting ↓
Strong Tower Advisory Services 404,972$6,913,0004.02%
GREAT POINT PARTNERS LLC 504,691$9,064,0002.11%
Camber Capital Management LP 3,750,000$67,350,0002.07%
ACT CAPITAL MANAGEMENT, LLC 161,500$2,901,0001.50%
Rhenman & Partners Asset Management AB 950,000$17,062,0001.20%
MAVERICK CAPITAL LTD 5,838,426$104,858,0001.06%
Birchview Capital, LP 72,000$1,293,0000.88%
Bellevue Group AG 4,594,656$82,519,0000.84%
CM Management, LLC 50,000$898,0000.67%
Duquesne Family Office 1,000,000$17,960,0000.58%
View complete list of NEKTAR THERAPEUTICS shareholders